About me
About me
Doctor of Philosophy University of Newcastle
Bachelor of Science (Honours) University of Sydney
Research
Excludes commercial-in-confidence projects.
Biopolymer films for enhanced wound management, Wound Management Innovation CRC, 16/02/2015 - 31/03/2018
Research
Research outputs for the last seven years are shown below. Some long-standing staff members may have older outputs included. To see earlier years visit ORCID, ResearcherID or Scopus
Open access indicates that an output is open access.
| Year | Output |
|---|---|
| 2020 |
Open access
23
21
20
|
| 2019 |
Open access
70
68
|
| 2017 |
Open access
12
12
|
| 2016 |
Open access
15
13
|
| Year | Output |
|---|---|
| 2025 |
Open access
|
| 2025 |
Open access
1
1
5
|
| 2025 |
Open access
|
| 2024 |
Open access
4
4
|
| 2024 |
1
1
|
| 2023 |
Open access
1
1
3
|
| 2023 |
Open access
7
9
|
| 2023 |
Open access
4
4
2
|
| 2023 |
6
5
|
| 2023 |
Open access
10
7
4
|
| 2022 |
5
5
3
|
| 2022 |
Open access
6
4
6
|
| 2022 |
Open access
5
4
7
|
| 2022 |
Open access
9
7
333
|
| 2021 |
Open access
10
10
4
|
| 2020 |
Open access
10
10
2
|
| 2020 |
Open access
23
21
20
|
| 2020 |
Open access
27
26
9
|
| 2019 |
Open access
70
68
|
| 2017 |
Open access
12
12
|
| 2017 |
Open access
3
3
|
| 2017 |
21
19
|
| 2016 |
Open access
15
13
|
| 2016 |
8
8
|
| 2015 |
Open access
48
46
3
|
| 2015 |
38
37
12
|
| 2015 |
37
34
9
|
| 2015 |
9
8
|
| 2014 |
10
10
|
| 2014 |
25
22
|
| 2013 |
10
10
|
| 2013 |
32
33
|
| 2013 |
9
10
|
| 2011 |
Open access
25
27
|
| 2011 |
63
61
|
| 2010 |
13
11
|
| 2008 |
10
8
|
| 2008 |
36
30
|
External engagement & recognition
| Organisation | Country |
|---|---|
| Aarhus University | DENMARK |
| Cardiff University | UNITED KINGDOM |
| Macquarie University | AUSTRALIA |
| Marinova Pty Ltd | AUSTRALIA |
| RDC Clinical Pty Ltd | AUSTRALIA |
| University of Adelaide | AUSTRALIA |
| University of Cambridge | UNITED KINGDOM |
| University of New South Wales | AUSTRALIA |
| University of Parma | ITALY |
| University of Queensland | AUSTRALIA |
| University of South Australia | AUSTRALIA |
| University of Technology Sydney | AUSTRALIA |
External engagement & recognition
| Engagement/recognition | Year |
|---|---|
MemberInternational Society of Pharmaceutical Engineering |
2017 |
MemberRoyal Australian Chemical Institute |
2017 |
Teaching & student supervision
Teaching & student supervision
Supervisions from 2010 shown
| Thesis title | Student status |
|---|---|
| 110502 - Developing advanced oral delivery formulations for treating leukemia | Current |
| A SN38 antibody prodrug conjugate strategy for cancer therapy | Current |
| Design of Lipid Nanoparticles (LNPs) for mRNA-Based Cancer Vaccines | Current |
| Engineering multifunctional hybrid materials for effective modulation of the gut microbiome | Current |
| Formulation Design and Development of Oral Chemotherapeutic Prodrugs: In Vitro, In Vivo, and In Silico Characterisation and Evaluation | Current |
| Lipid nanoparticles for delivery of nucleic acid vaccines | Current |
| Lipid-based formulations to overcome challenges in oral drugdelivery | Current |
| An infrared spectroscopic study of fucoidan/chitosan polyelectrolyte multilayers for biomedical applications | Completed |
| Biophysics of pulmonary surfactant under thermal stress | Completed |
| Cationic polymer mediated siRNA complexes: relationship between intracellular delivery and physicochemical properties | Completed |
| Combining porous nanostructure and lipid carriers to improve oral delivery systems for poorly water soluble drugs | Completed |
| Formation and characterisation of fucoidan-based polyelectrolyte multilayers for applications in biomaterials | Completed |
| Liposome-micelle hybrid systems for oral delivery of poorly water-soluble cardiovascular drug lovastatin and anticancer drugs paclitaxel and 5-fluorouracil | Completed |
| Optimizing silica encapsulated lipid-based oral drug delivery systems | Completed |
| Solid nanostructured formulations for the oral delivery of poorly water-soluble drugs: from bench to bedside | Completed |
| The role of formulations in skin delivery | Completed |
